Results 131 to 140 of about 2,000 (177)

Effectiveness and Safety of Lenacapavir-Containing Regimens in Highly Experienced HIV-Infected Patients With Multidrug Resistance: Real-world Results From the French Compassionate Use Program ^a. [PDF]

Open Forum Infect Dis
Delaugerre C, Mafi S, Zenuni A, Peytavin G, Amat K, Seang S, Duvivier C, Chirio D, Viard JP, Hocqueloux L, Estrabaud E, Ghosn J, Landman R, Assoumou L, Charpentier C, Lacombe K.   +15 more
europepmc   +1 more source

Combined injectable regimens in treatment-experienced HIV/AIDS patients at a southern academic medical center: a case series. [PDF]

BMC Infect Dis
Burton HJ, Rivere E, Kirk S, Berry H, Lueking R.   +4 more
europepmc   +1 more source

Research progress on HIV-1 structural proteins and antiviral therapies. [PDF]

Front Immunol
Wang H, Yuan J, Wang H.
europepmc   +1 more source

A Concise Process to Lenacapavir Sodium: Demonstration of One-Pot Sequential Heck/Suzuki-Miyaura Couplings in Lenacapavir API Synthesis. [PDF]

Org Process Res Dev
Guthrie D, Shinde AH, Vediyappan R, Nunes De Souza A, Sayini RK, Saathoff JM, Sakkani N, Asad N, Hochstetler SR, Stubbs B, Burns JM, Gupton BF, Littich R, Jin L.   +13 more
europepmc   +1 more source

Baseline and week 48 resistance analysis in participants receiving bictegravir + lenacapavir in the phase 2 ARTISTRY-1 study. [PDF]

AIDS
Pennetzdorfer N, Naik V, Montezuma-Rusca JM, Sklar P, Callebaut C, Margot NA.   +5 more
europepmc   +1 more source

Accelerating Subcutaneous Drug Development: A Mechanistic Absorption Model for the Open Systems Pharmacology Framework. [PDF]

CPT Pharmacometrics Syst Pharmacol
Pellowe M, Dubbelboer I, Sjögren E.
europepmc   +1 more source

Recent Developments in HIV Antivirals: The Prospect of Prophylactic Drugs to Change the Pandemic. [PDF]

Microb Biotechnol
Brüssow H.
europepmc   +1 more source

HIV-1 integrase inhibitor resistance in viraemic-treated individuals and baseline capsid diversity relevant to future lenacapavir therapy. [PDF]

J Antimicrob Chemother
Abdullahi A, Osawe S, Wisso H, Edun M, Adebisi G, Arachie J, Ude C, Onyemata J, Alhaji SY, Bara Jibrin Y, Abimiku A, Kemp SA, Gupta RK.   +12 more
europepmc   +1 more source